Hans Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 17-11-2024
- Paid Up Capital ₹ 2.50 M
as on 17-11-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.99 Cr
as on 17-11-2024
- Satisfied Charges ₹ 0.56 M
as on 17-11-2024
- Revenue 28.24%
(FY 2023)
- Profit -80.36%
(FY 2023)
- Ebitda 34.45%
(FY 2023)
- Net Worth 2.62%
(FY 2023)
- Total Assets 26.24%
(FY 2023)
About Hans Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.99 Cr. The company has closed loans amounting to ₹0.56 M, as per Ministry of Corporate Affairs (MCA) records.
Kaushik Champaklal and Himanshu Shah serve as directors at the Company.
- CIN/LLPIN
U24100MH2004PTC148312
- Company No.
148312
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hans Chemicals Private Limited offer?
Hans Chemicals Private Limited offers a wide range of products and services, including Inorganic Acids, Phosphoric Acid, Flavours & Aromatics, Food Acidulant, Alcohol Solvents, Polyethylene Glycol PEG, Insecticides and Pesticides, Herbicides, Chemical Intermediates, Carbolic Acid.
Who are the key members and board of directors at Hans Chemicals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kaushik Champaklal | Director | 31-Aug-2004 | Current |
Himanshu Shah | Director | 31-Aug-2004 | Current |
Financial Performance of Hans Chemicals.
Hans Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.24% increase. The company also saw a substantial fall in profitability, with a 80.36% decrease in profit. The company's net worth moved up by a moderate rise of 2.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hans Chemicals?
In 2023, Hans Chemicals had a promoter holding of 50.40% and a public holding of 49.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹29.90 M
₹0.56 M
Charges Breakdown by Lending Institutions
- Bank Of India : 2.99 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Aug 2007 | Bank Of India | ₹2.99 Cr | Open |
08 Oct 2010 | Bank Of India | ₹0.30 M | Satisfied |
20 Jan 2009 | Bank Of India | ₹0.26 M | Satisfied |
How Many Employees Work at Hans Chemicals?
Unlock and access historical data on people associated with Hans Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hans Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hans Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.